Medications for Chronic Myelogenous Leukemia

Other names: Cancer, Chronic Myelogenous Leukemia; Chronic Granulocytic Leukemia; Chronic Myeloid Leukemia; CML; Leukemia, Chronic Granulocytic

Chronic Myelogenous Leukemia is cancer that starts inside bone marrow. Chronic Myelogenous Leukemia causes an uncontrolled growth of immature cells that make a certain type of white blood cell called myeloid cells. The diseased cells build up in the bone marrow and blood.

Drugs used to treat Chronic Myelogenous Leukemia

Name Drug Class Updated
Busulfan (oral/injection) Alkylating agents 16-Aug-2023
Fludarabine (injection) Antimetabolites 16-Aug-2023
Bosutinib BCR-ABL tyrosine kinase inhibitors 15-Aug-2023
Dasatinib BCR-ABL tyrosine kinase inhibitors 14-Aug-2023
Cytarabine Antimetabolites 13-Aug-2023
Omacetaxine Miscellaneous antineoplastics 11-Aug-2023
Ponatinib BCR-ABL tyrosine kinase inhibitors 11-Aug-2023
Nilotinib BCR-ABL tyrosine kinase inhibitors 11-Aug-2023
Asciminib BCR-ABL tyrosine kinase inhibitors 11-Aug-2023
Anagrelide Miscellaneous coagulation modifiers 11-Aug-2023
Tasigna BCR-ABL tyrosine kinase inhibitors 14-Jul-2023
Synribo Miscellaneous antineoplastics 14-Jul-2023
Scemblix BCR-ABL tyrosine kinase inhibitors 14-Jul-2023
Fludarabine (monograph) Drugs 25-Aug-2023
Bosulif BCR-ABL tyrosine kinase inhibitors 13-Jul-2023
Sprycel BCR-ABL tyrosine kinase inhibitors 12-Jul-2023
Imatinib BCR-ABL tyrosine kinase inhibitors 10-Jul-2023
Iclusig BCR-ABL tyrosine kinase inhibitors 10-Jul-2023
Hydroxyurea Antimetabolites 10-Jul-2023
Hydrea Antimetabolites 10-Jul-2023
Gleevec BCR-ABL tyrosine kinase inhibitors 10-Jul-2023
Nilotinib (systemic) (monograph) Drugs 12-Oct-2023
Dasatinib (systemic) (monograph) Drugs 12-Oct-2023
Ponatinib (systemic) (monograph) Drugs 12-Oct-2023
Share this Article
Latest News
Related Drugs